CGT

1,163개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,163 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTAAVLimited DatastaleWeill Medical College of Cornel…Phase 1

AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies (AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies)

Batten Disease; Late-Infantile Neuronal Ceroid Lipofuscinosis · Batten Disease

#BattenDisease#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleAskBio France, SAS, a subsidiar…Phase 2

AB-1001 Gene Therapy (AB-1001 Gene Therapy)

Huntington Disease · Huntington Disease

#HuntingtonDisease#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleZhejiang UniversityPhase 1

ADGRE2 CAR-T (ADGRE2 CAR-T)

AML · AML

#AML#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleAdicet TherapeuticsPhase 2

ADI-270 (ADI-270)

Clear Cell Renal Cell Carcinoma · Clear Cell Renal Cell Carcinoma

#ClearCellRenalCellCarcinoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleInge Marie SvanePhase 1

ADP-TILIL7 (ADP-TILIL7)

Melanoma Stage III; Melanoma Stage IV · Melanoma Stage III

#MelanomaStageIII#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleCandel Therapeutics, Inc.Phase 2

ADV-TK (ADV-TK, adenovirus-thymidine kinase enzyme, ADV-TK (adenovirus-thymidine kinase enzyme) gene therapy)

Hepatocellular Carcinoma; Liver Transplantation · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleGuangzhou Anjie Biomedical Tech…Phase 2

AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

Advanced Breast Cancer; Breast Neoplasm Malignant Female · PD-1

#PD-1#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

ALTCAR.CD30 cells (ALTCAR.CD30 cells)

Lymphoma; Immune System Diseases · CD30

#CD30#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 2

AMT-116 CAR-T cells (AMT-116 CAR-T cells)

Melanoma; Non-small Cell Lung Cancer · Melanoma

#Melanoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 2

AMT-253 CAR-T cells (AMT-253 CAR-T cells)

Melanoma; Non-small Cell Lung Cancer · Melanoma

#Melanoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTAAVLimited DatastaleAtamyo TherapeuticsPhase 1

AAV9 encoding FKRP gene (ATA-100, ATA-100 (AAV9 encoding FKRP gene))

LGMDR9 · LGMDR9

#LGMDR9#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Preclinical

ATLCAR.CD30 (ATLCAR.CD30)

Hodgkin Lymphoma, Adult · CD30

#CD30#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

ATLCAR.CD30.CCR4 cells (ATLCAR.CD30.CCR4 cells)

Lymphoma; Immune System Diseases · CD30

#CD30#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleAutolus LimitedPhase 2

AUTO CAR T cell therapy (AUTO CAR T cell therapy)

Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy; Multiple Myeloma · Patients Followed for up to 15 Years Fol

#PatientsFollowedforupto15YearsFo#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleCytoMed Therapeutics Pte LtdPhase 1

Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell (Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell)

Colorectal Cancer; Triple Negative Breast Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleAvenCell Therapeutics, Inc.Phase 2

Allo-QuadCAR01-T (Allo-QuadCAR01-T)

Lymphoma Diffuse Large B-cell; Leukemia and Lymphoma · Lymphoma Diffuse Large B-cell

#LymphomaDiffuseLargeB-cell#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleAvenCell Europe GmbHPhase 1

Allo-RevCAR01-T (Allo-RevCAR01-T)

Acute Myeloid Leukemia, in Relapse; Acute Myeloid Leukemia Refractory · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleInstituto de Investigación Hosp…Phase 1

Allogeneic CART-NKG2D cells (Allogeneic CART-NKG2D cells)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · Precursor Cell Lymphoblastic Leukemia-Ly

#PrecursorCellLymphoblasticLeukem#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleMustang Bio, Inc.Phase 1

Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes (Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes)

Adult Acute Myeloid Leukemia in Remission; Acute Biphenotypic Leukemia · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleBaylor College of MedicinePhase 1

Allogeneic CD5.CAR/28zeta CAR T cells (Allogeneic CD5.CAR/28zeta CAR T cells)

T-cell Acute Lymphoblastic Lymphoma; T-non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Lymphoma

#T-cellAcuteLymphoblasticLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting

23 / 59 pages

← PreviousNext →